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An increase in depressive symptoms after myocardial
infarction predicts new cardiac events irrespective of
depressive symptoms before myocardial infarction
M. Zuidersma1*, J. Ormel1, H. J. Conradi1,2 and P. de Jonge1
1 Interdisciplinary Center for Psychiatric Epidemiology, Department of Psychiatry, University Medical Center Groningen, University of
Groningen, The Netherlands
2 Department of Clinical Psychology, University of Amsterdam, The Netherlands
Background. Depression after myocardial infarction (MI) is associated with poor cardiovascular prognosis. There
is some evidence that speciﬁcally depressive episodes that develop after the acute event are associated with poor
cardiovascular prognosis. The aim of the present study was to evaluate whether an increase in the number of
depressive symptoms after MI is associated with new cardiac events.
Method. In 442 depressed and 325 non-depressed MI patients the Composite International Diagnostic Interview
interview to assess post-MI depression was extended to evaluate the presence of the ICD-10 depressive symptoms
just before and after the MI. The eﬀect of an increase in number of depressive symptoms during the year following
MI on new cardiac events up to 2.5 years post-MI was assessed with Cox regression analyses.
Results. Each additional increase of one symptom was signiﬁcantly associated with a 15% increased risk of new
cardiac events, and this was stronger for non-depressed than for depressed patients. This association was
independent of baseline cardiac disease severity. There was no interaction with the number of depressive symptoms
pre-MI.
Conclusions. Our ﬁndings suggest that an increase in depressive symptoms after MI irrespective of the state of
depression pre-MI explains why post-MI depression is associated with poor cardiovascular prognosis. Also increases
in depressive symptoms after MI resulting in subthreshold depression should be evaluated as a prognostic marker.
Whether potential mechanisms such as cardiac disease severity or inﬂammation underlie the association remains to
be clariﬁed.
Received 15 March 2011 ; Revised 25 May 2011 ; Accepted 1 August 2011 ; First published online 6 September 2011
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Introduction
In myocardial infarction (MI) patients, the prevalence
of depressive disorder is about 20% (Thombs et al.
2006), compared with 2% in the general population of
comparable age (Beekman et al. 1999). Moreover, de-
pressed MI patients have a twofold increased risk of
poor cardiac prognosis, including all-cause mortality,
cardiovascular mortality and new cardiovascular
events than those who are not depressed (Meijer et al.
2011).
Recent studies suggest that this risk of poor prog-
nosis diﬀers among subgroups of depressed cardiac
patients. At particularly increased risk are those with
persistent or treatment-resistant depression (Carney
et al. 2004 ; Kaptein et al. 2006 ; de Jonge et al. 2007 ;
Glassman et al. 2009), somatic depressive symptoms
(de Jonge et al. 2006a ; Linke et al. 2009 ; Martens et al.
2010), anhedonia (Davidson et al. 2010) and ﬁrst-ever
depressive episodes (Grace et al. 2005 ; Carney et al.
2009).
There is some evidence that depressed MI patients
are at particular increased risk of poor prognosis when
the depressive episode has an onset after rather than
before the acute event (de Jonge et al. 2006b ; Dickens
et al. 2008 ; Parker et al. 2008), but results are incon-
sistent (Glassman et al. 2009 ; Zuidersma et al. 2011).
Moreover, MI patients with depressive episodes with
an onset after the MI were found to have had a more
severe MI than those with depressive episodes with an
onset before the MI (Spijkerman et al. 2005).
The ﬁnding that the onset of the depressive
episode relative to the MI is associated with new
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cardiovascular events helps in identifying those de-
pressed MI patients with the highest risk. Further-
more, it suggests that the prognostic impact of post-MI
depression has an aetiology related to the MI itself.
Depression after MI results from either a prolongation
of a pre-existing depression or an increase in de-
pressive symptoms after the event, or both. The ﬁnd-
ing that depressive episodes with an onset after the
MI are associated with new cardiovascular events
suggests that it is the increase in depressive symptoms
after the MI that explains the poor prognosis as-
sociated with depression. Therefore, an increase in
depressive symptoms after MI could also be as-
sociated with poor prognosis if it does not lead to a
full diagnosis of depression, or if it occurs on top of
a pre-existing depressive episode. No study has yet
evaluated whether cardiac prognosis is associated
with an increase in depressive symptoms after MI as a
continuous measure. In the present study we evaluate
whether an increase in depressive symptoms after MI
is associated with poor prognosis in the presence and
absence of post-MI depression.
Method
Description of the studies and participants
The present analysis included depressed and non-
depressed MI patients enrolled in two studies : (1) the
Depression after Myocardial Infarction study
(DepreMI) – a prognostic study evaluating the eﬀects
of depression on cardiovascular prognosis in MI
patients ; and (2) the Myocardial Infarction and De-
pression Intervention Trial (MIND-IT) – a randomized
controlled trial evaluating the eﬀects of antidepressant
treatment in depressed MI patients. Both studies were
highly similar in patient recruitment, eligibility cri-
teria, assessment of depression and participation rates.
DepreMI
DepreMI was a prognostic study evaluating the eﬀects
of depression on cardiovascular prognosis in MI
patients receiving usual cardiac aftercare. Details
of this study have been described previously
(Spijkerman et al. 2006). Patients admitted for MI were
recruited from four hospitals in the north of the
Netherlands between September 1997 and September
2000. To be included, patients had to have chest pain
for at least 20 min, increased enzyme levels, and new
pathological Q-waves on the electrocardiogram in at
least two leads. Excluded were patients with a life ex-
pectancy of less than a year due to non-cardiac con-
ditions, poor physical function, cognitive dysfunction,
who were unable to speak or read Dutch, and when
follow-up visits were scheduled in a non-participating
hospital. The study protocol was approved by the
ethics committee review board of each of the four
participating hospitals.
MIND-IT
MIND-IT was a multicentre randomized controlled
trial evaluating the eﬀects of antidepressant treatment
in depressed MI patients (for details, see van den
Brink et al. 2002; van Melle et al. 2007). Brieﬂy, patients
admitted for MI to one of 11 hospitals in the
Netherlands were recruited consecutively between
September 1999 and November 2002. To be included,
patients had to beo18 years of age, and had to have a
documented increase in cardiac enzymes together
with chest pain during at least 20 min or typical
electrocardiographic changes. Exclusion criteria were
the presence of a disease likely to inﬂuence short-time
survival, being unable to participate (e.g. not able to
communicate or not available for follow-up), already
receiving psychiatric care for depression, and partici-
pating in another clinical trial. The intervention in-
cluded prescription of antidepressant medication
and/or referral to psychotherapy. The institutional
review board at each clinical centre approved the
protocol. The treatment was not eﬀective in improving
long-term depression status (i.e. 18 months post-MI)
nor in reducing the risk of new cardiac events (van
Melle et al. 2007).
Assessment of demographic and clinical parameters
Demographic and clinical characteristics were as-
sessed during hospital admission for the index MI
and from hospital charts. The presence of diabetes
mellitus was assessed from the medical charts during
hospital stay for the indexMI. Smoking was deﬁned as
current smoker or quit smoking less than 3 months
before hospital admission. Left ventricular ejection
fraction (LVEF) was assessed by echocardiography,
radionuclide ventriculography, gated single photon
emission computed tomography, magnetic resonance
imaging, angiography or clinical assessment. In
MIND-IT, a modiﬁed version (Watkins et al. 2003) of
the Charlson Comorbidity Index (Charlson et al. 1987)
was calculated as a composite measure of somatic co-
morbidities.
Assessment of a diagnosis of depression
In DepreMI, at 3 and 12 months after the MI, the
presence of a post-MI depressive episode according
to International Classiﬁcation of Diseases, 10th re-
vision (ICD-10) criteria (World Health Organization,
1993) was assessed with the Composite International
Diagnostic Interview version 1.1 (CIDI ; World Health
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Organization, 1990). In MIND-IT, patients were
screened for depressive symptoms with the Beck
Depression Inventory (BDI) (Beck et al. 1979) in the
hospital and at 3 months after the MI. Those scoring
10 or higher were administered the CIDI, version 2.1
at 3 months after the MI to assess whether ICD-10
criteria for a post-MI depressive episode were met.
Those with a score below 10 on the BDI and those who
did not meet ICD-10 criteria for a post-MI depressive
episode were assessed for depression again 3 months
later. Assessments for depression were made up to
12 months after the MI.
Change in depressive symptoms after MI
In both studies, the change in depressive symptoms
after MI was obtained from the ﬁrst CIDI interview
where the diagnosis of depression was made (i.e. 3, 6,
9 or 12 months after the MI for depressed patients and
3 months after the MI for non-depressed patients).
For this goal, the CIDI was extended with additional
questions to assess the presence of each ICD-10
symptom of depression during the 4 weeks before MI
and after the MI. Symptoms were graded as either
present or absent. A change score was calculated by
subtracting the number of depressive symptoms
present during the 4 weeks before the MI from the
number of depressive symptoms present after the MI.
In MIND-IT, the presence of depressive symptoms
just before and after the MI was not assessed in non-
depressed patients. Therefore, non-depressed patients
were included from DepreMI only.
New cardiac events
New fatal and non-fatal cardiac events occurring after
the depression interview were included as endpoints
and were assessed by patient interviews, hospital re-
cords and data from treating specialists. Endpoints
included cardiac deaths and hospital readmissions
for recurrent MI, unstable angina, heart failure and
arrhythmia. An independent endpoint committee
consisting of at least two cardiologists evaluated
whether potential endpoints were cardiac related. The
follow-up period started at the date of the interview
where the diagnosis for depression was established
(i.e. 3, 6, 9 or 12 months post-MI for depressed patients
and 3 months post-MI for non-depressed patients) and
lasted up to 18 months (MIND-IT) or 2.5 years after the
index MI (DepreMI).
Statistics
First, demographic and clinical characteristics at the
time of the MI were compared between included
and excluded study participants with the x2 or the
independent-sample Student’s t test. This was re-
peated for the patients with and without data on new
cardiac events.
Next, for the included patients, demographic and
clinical characteristics were associated with the con-
tinuous measure of the change in number of depress-
ive symptoms after MI with the Mann–Whitney U test
and Spearman correlation.
Cox regression was used to assess whether time to
ﬁrst new cardiac event was associated with an increase
in depressive symptoms after MI. A hazard ratio (HR)
was calculated for new cardiac events associated with
each symptom increase. Adjustments for covariables
were made stepwise : model 1 adjusted for age and
sex, model 2 additionally for LVEF and previous MI
because these relate to both depression and cardiac
prognosis (van Melle et al. 2005 ; Naqvi et al. 2007),
model 3 additionally for diabetes and smoking be-
cause these relate to depression as well as cardiac
disease (Critchley & Capewell, 2003 ; Dawood et al.
2008 ; Mezuk et al. 2008), and model 4 additionally
adjusted for those cardiac parameters that were as-
sociated with an increase in the number of depressive
symptoms after MI to explore the possibility that other
cardiac disease severity parameters explain the as-
sociation between an increase in number of depressive
symptoms after MI and new cardiac events.
To evaluate whether the presence of somatic co-
morbidities could explain the association between an
increase in depressive symptoms and cardiac events,
adjustments were made for the Charlson Comorbidity
Index. This was done for MIND-IT patients only,
because the Charlson Comorbidity Index was only
assessed in MIND-IT. To evaluate whether the occur-
rence of new cardiac events before depression assess-
ment confounded the association between an increase
in depressive symptoms after MI and new cardiac
events : (1) adjustment was made for new cardiac
events before the interview; and (2) patients with a
cardiac event before depression assessment were ex-
cluded. This was done for DepreMI only, because
in MIND-IT new cardiac events occurring before the
depression assessment were not assessed.
Next, the presence of a dose–response relationship
between an increase in depressive symptoms and
cardiac events was evaluated. First, it was evaluated
whether the risk of having a new cardiac event linearly
increases with larger increases in depressive symp-
toms. For this purpose, the HR for new cardiac events
associated with an increase of (1) one or two, (2) three
or four, or (3) more than four symptoms increase was
calculated, using a decrease or no change in number
of symptoms as a reference. Second, it was evaluated
whether an increase in depressive symptoms is lin-
early associated with the number of new cardiac
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events by calculating a Spearman correlation between
the increase in number of depressive symptoms and
the total number of cardiac events per follow-up year.
Next, to evaluate whether the association between
an increase in number of depressive symptoms after
MI and new cardiac events diﬀers between patients
with few and many symptoms just before the MI, an
interaction term was calculated of the number of de-
pressive symptoms pre-MI and the increase in number
of depressive symptoms after MI. With Cox regression
the HR for new cardiac events was calculated for the
interaction term with the two main terms in the same
model, and in a next step additionally with all covari-
ables included in model 4. A multicollinearity test was
done for the number of depressive symptoms pre-MI,
the increase in depressive symptoms after MI and the
interaction term.
As a sensitivity analysis, the survival analyses
were repeated for : (1) depressed and non-depressed
patients separately to evaluate whether results diﬀer
for patients with and without an ICD-10 diagnosis of
post-MI depression ; and (2) only patients who had a
CIDI at 3 months post-MI to evaluate whether results
diﬀer due to the timing of assessment of change in
depression symptoms after MI. The signiﬁcance level
for all analyses was set at p<0.05 (two-tailed).
Results
Sample
A ﬂow chart for patients of DepreMI and MIND-IT is
shown in Fig. 1. Of the 2705 participants (2177 from
MIND-IT and 528 from DepreMI), 835 (31%) patients
had complete data on the change in number of de-
pressive symptoms after MI. Of these 835 patients,
new cardiac events were evaluated in 767 (92%)
patients, of whom 442 met ICD-10 criteria for a post-
MI depressive episode. Of these 767 patients, 163
(21.3%) had a new cardiac event during a mean
follow-up time of 1.43 (S.D.=0.86) years.
Characteristics of included and excluded patients
Compared with the 1938 excluded patients, the 767
who were included in the present analysis were
younger, more likely to be smokers, to have lower
LVEF, higher Killip class, to have thrombolysis during
hospitalization for the index MI, more likely to be
prescribed a calcium channel blocker, less likely to
have hypercholesterolaemia and less likely to be pre-
scribed statins and beta-blockers. Included and ex-
cluded participants did not diﬀer on sex, body mass
index (BMI), smoking, anterior site MI, revascular-
ization during hospitalization for index MI, history of
MI, family history of coronary artery disease (CAD),
diabetes, hypertension, peripheral vascular disease,
cerebrovascular disease, and the Charlson Comorbid-
ity Index (assessed in MIND-IT only).
Compared with the 767 included patients, the 68
with no data on new cardiac events more often had
percutaneous transluminal coronary angioplasty
(PTCA) and less often thrombolysis during hospital-
ization for index MI. They did not diﬀer on any of the
other investigated clinical variables (see above).
Prevalence of depressive symptoms before and
after MI
Table 1 shows for each of the ten ICD-10 symptoms of
depression the number of patients and percentages
with the symptom before and after the MI. This is
done separately for the 442 patients with post-MI de-
pression and the 325 non-depressed patients. It shows
that the largest proportion of depressive symptoms
after the MI is attributable to new development.
However, there seems to be no diﬀerence in new de-
velopment between individual symptoms. In addition,
the proportion of patients reporting a symptom to be
present before MI but absent after MI was very small,
ranging between 0.8% (appetite problems) and 5.5%
(fatigue).
Change in number of depressive symptoms after
MI and baseline characteristics
Table 2 compares demographic and clinical charac-
teristics for 272 patients with a decrease or no change
in depressive symptoms after MI and 495 patients
with an increase in depressive symptoms after MI. An
increase in the number of depressive symptoms was
associated with younger age, smoking, low LVEF, an-
terior site MI, PTCA during admission for the index
MI, a family history of CAD, hypercholesterolaemia,
and with ﬁrst-ever depression.
Change in number of depressive symptoms after MI
and new cardiac events
Fig. 2 shows the mean [95% conﬁdence interval (CI)]
number of depressive symptoms during the 4 weeks
before MI and after the MI for patients who suﬀered a
new cardiac event and those who remained event-free.
Table 3 shows the results of the survival analysis. An
increase of one depressive symptom was signiﬁcantly
associated with a 15% increased risk of new cardiac
events. Adjustment for age, sex, LVEF, previous MI,
presence of diabetes and smoking did not aﬀect this
association. Neither did adjustment for the cardiac
parameters that were signiﬁcantly associated with an
increase in depressive symptoms after MI (anterior
686 M. Zuidersma et al.
site MI, PTCA during hospitalization for index MI,
family history of CAD, hypercholesterolaemia).
Adjustment for the Charlson Comorbidity Index in
MIND-IT patients did not aﬀect the HR. Adjustment
for new cardiac events before the depression assess-
ment aﬀected the HR only slightly (from 1.09 to 1.07),
as did exclusion of the 45 patients with a new cardiac
event before depression assessment (HR 1.08).
There was a dose–response relationship between an
increase in depressive symptoms and cardiac events,
with unadjusted HRs of 1.70 (95% CI 1.09–2.66,
p=0.020), 2.11 (95% CI 1.32–3.35, p=0.002) and 2.88
(95% CI 1.89–4.38, p<0.001) for an increase in one
or two, three or four, and more than four symptoms,
respectively. In addition, the increase in number of
depressive symptoms was positively correlated with
the number of new cardiac events per follow-up year
(r=0.153, p<0.001 ; see also Fig. 3).
The interaction term of the number of depressive
symptoms pre-MI and the change in number of de-
pressive symptoms after MI did not reach statistical
signiﬁcance. There was no multicollinearity between
the number of symptoms pre-MI, the increase in de-
pressive symptoms after MI and the interaction term
(variance inﬂating factor varied between 1.16 and
1.42). The number of symptoms during the 4 weeks
before MI was not associated with new cardiac




























835 with data on depressive symptoms just
before and after MI
26 DepreMI patients no cardiac
events assessed after
depression assessment
41 MIND-IT patients not followed
for cardiac events due to designa
1 MIND-IT patient lost
767 with complete data on depressive symptoms
and new cardiac events
442 post-MI depression
325 no post-MI depression
468 with complete
data on depression
Fig. 1. Flow-chart for patients of the Depression after Myocardial Infarction (DepreMI) study and Myocardial Infarction and
Depression Intervention Trial (MIND-IT). CIDI, Composite International Diagnostic Interview ; MI, myocardial infarction.
a These patients were not randomized and therefore not followed for new cardiac events.
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Table 1. Prevalence of each ICD-10 depressive symptom during the 4 weeks before MI and after the MI, assessed in 767 MI patients
Patients with diagnosis of post-MI
depression (n=442)














Sadness 102 (23.1) 328 (74.2) 240 (73.2) 9 (2.8) 12 (3.7) 9 (75.0)
Loss of interest 81 (18.3) 278 (62.9) 214 (77.0) 12 (3.7) 19 (5.8) 13 (68.4)
Worthless/guilty 44 (10.0) 176 (39.8) 143 (81.2) 6 (1.8) 13 (4.0) 8 (61.5)
Low self-esteem 45 (10.2) 177 (40.0) 145 (81.9) 7 (2.2) 9 (2.8) 2 (22.2)
Concentration problems 93 (21.0) 314 (71.0) 236 (75.2) 23 (7.1) 62 (19.1) 50 (80.6)
Thoughts of death/suicide 40 (9.0) 166 (37.6) 133 (80.1) 8 (2.5) 19 (5.8) 14 (73.7)
Fatigue 141 (31.9) 363 (82.1) 236 (65.0) 49 (15.1) 60 (18.5) 39 (65.0)
Appetite problems 6 (1.4) 48 (10.9) 46 (95.8) 3 (0.9) 9 (2.8) 8 (88.9)
Sleeping problems 135 (30.5) 329 (74.4) 207 (62.9) 60 (18.5) 107 (32.9) 60 (56.1)
Psychomotor changes 76 (17.2) 238 (53.8) 180 (75.6) 24 (7.4) 42 (12.9) 27 (64.3)
ICD, International Classiﬁcation of Diseases, 10th revision ; MI, myocardial infarction.
Data are given as n (%).














Mean age, years (S.D.) 60.7 (11.2) 59.1 (11.5) x0.101**
Male, n (%) 219 (80.5) 376 (76.0) x1.476
Mean BMI, kg/m2 (S.D.) 26.9 (4.2) 26.6 (4.1) x0.033
Smoking, n (%) 116 (45.8) 266 (56.4) x2.322*
Cardiac parameters
Low LVEFa, n (%) 71 (26.7) 159 (33.8) x2.499*
Anterior site of MI, n (%) 75 (27.6) 179 (36.2) x2.360*
Killip classo2, n (%) 40 (14.7) 69 (14.0) x0.375
PTCA during hospitalization, n (%) 74 (27.7) 185 (38.6) x4.901***
CABG during hospitalization, n (%) 15 (5.6) 14 (2.9) x1.523
Thrombolysis during hospitalization, n (%) 119 (44.2) 207 (42.0) x1.114
History of MI, n (%) 44 (16.2) 69 (14.0) x1.005
Family history of CAD, n (%) 103 (38.0) 226 (46.0) x3.460**
Co-morbidity
Diabetes, n (%) 25 (9.2) 61 (12.3) x0.603
Hypertension, n (%) 87 (32.0) 151 (30.5) x0.050
Hypercholesterolaemia, n (%) 113 (41.5) 312 (63.2) x6.848***
Peripheral vascular disease, n (%) 18 (6.6) 47 (9.5) x1.059
Cerebrovascular disease, n (%) 12 (4.4) 25 (5.1) x0.419
First-ever depressionb, n (%) 41 (65.1) 305 (80.5) x2.831**
MI, Myocardial infarction ; S.D., standard deviation ; BMI, body mass index ; LVEF, left ventricular ejection fraction ; PTCA,
percutaneous transluminal coronary angioplasty ; CABG, coronary artery bypass grafting ; CAD, coronary artery disease.
a Depression after Myocardial Infarction study (DepreMI) :f40%, Myocardial Infarction and Depression Intervention Trial
(MIND-IT) :f45%.
b In 442 patients with post-MI depression (n=92,<2 symptoms increase ; n=350,o2 symptoms increase).
* p<0.05, ** p<0.01, *** p<0.001.
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signiﬁcantly associated with new cardiac events,
where each additional symptom accounted for a 15%
increased risk.
The ﬁrst sensitivity analysis showed that in the 442
MI patients with a post-MI depressive episode the as-
sociation of an increase in the number of depressive
symptoms after MI and new cardiac events was much
weaker than in 325 non-depressed MI patients (see
Table 3).
The second sensitivity analysis showed that after
exclusion of 134 patients with a CIDI interview at 6, 9
or 12 months, the associations as shown in Table 3
were essentially the same (data not described here, but
can be requested from M.Z.).
Discussion
In the present analysis we evaluated whether an in-
crease in the number of depressive symptoms after MI
rather than the prolongation of a pre-existing de-
pressive episode explains why post-MI depression is
associated with poor cardiac prognosis. We found a
dose–response relationship between an increase in the
number of depressive symptoms after MI and risk of
new cardiac events. An increase of one single ICD-10
symptom (of which there are 10) was associated with a
15% increased risk. Although an increase in the num-
ber of depressive symptoms after MI was associated
with cardiac disease severity at baseline, adjustment
for cardiac disease severity did not aﬀect the associ-
ation with new cardiac events. Furthermore, there was
no interaction with the number of depressive symp-
toms pre-MI. This result suggests that it is the increase
in depressive symptoms rather than the state of de-
pression pre-MI that explains why post-MI depression
is associated with new cardiac events.
Our study has a number of strengths. This is to our
knowledge the ﬁrst time that the impact of an increase
in depression severity from just before to after an acute
cardiac event on cardiac prognosis has been evaluated.
We used a large sample of MI patients with and
without post-MI depression and assessed the number
of depressive symptoms just before and after the MI in
a face-to-face interview. The sample was large enough
to adjust for factors potentially confounding the as-
sociation between the increase in depressive symp-
toms and new cardiac events. To evaluate to what
extent our ﬁndings can be generalized to the whole MI
population, patients included in the present analysis
were compared with excluded participants on base-
line demographic and medical characteristics. The
oversampling of MI patients with a diagnosis of de-
pression probably explains why the included patients
had a slightly worse cardiac proﬁle than those who
were excluded. Apart from this, included patients
were not much diﬀerent from excluded patients. We
therefore conclude that the associations we found are
very likely to be representative for at least all study
participants. In addition, there were no major diﬀer-
ences in baseline characteristics between patients with
and without data on new cardiac events.
A study that is somewhat comparable with ours is
that of Dickens et al. (2008). In their study, 440 MI
patients completed the Hospital Anxiety and De-
pression Scale (HADS) at two time points : (1) during
hospitalization, but assessing depressive symptoms
during the week preceding MI; and (2) at 12 months
after the MI. They found that patients with new-onset
depression (i.e. HADS score <17 preceding MI and
o17 at 12 months post-MI) were at increased risk of
cardiac mortality up to 8 years post-MI compared with
patients with pre-MI-onset depression (HADS score
o17 preceding MI) and non-depressed patients
(HADS score <17 at both time points). Despite the
diﬀerence in assessing the increase in depressive
symptoms after MI (i.e. as a continuous measure with
a diagnostic interview versus a cut-oﬀ score on a
questionnaire), our ﬁnding is consistent with that of
Dickens et al. (2008).
It may be that MI patients with depressive episodes
with an onset after the MI are at increased risk of new
cardiac events (de Jonge et al. 2006b ; Dickens et al.
2008), because these patients show a larger increase in
depressive symptoms after MI. That the increased risk
associated with an increase in depressive symptoms
after MI is comparable for patients with few and many
symptoms of depression pre-MI suggests that an in-



























Fig. 2. Number of symptoms of depression during the
4 weeks before and after the myocardial infarction (MI) in
patients with ( , n=163) and without (&, n=604) a new
cardiac event. Values are means, with 95% conﬁdence
intervals represented by vertical bars.
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Table 3. Risk of new cardiac events associated with the number of depressive symptoms just before and after MI and with an increase in number of depressive symptoms after MI
Predictor
All patients (n=767) Post-MI depression (n=442) No post-MI depression (n=325)
HR (95% CI)a p HR (95% CI)a p HR (95% CI)a p
Increase in number of symptoms
Unadjusted 1.15 (1.09–1.21) <0.001 1.08 (1.01–1.16) 0.022 1.21 (1.00–1.46) 0.046
Model 1b 1.15 (1.09–1.22) <0.001 1.08 (1.01–1.16) 0.021 1.24 (1.02–1.52) 0.032
Model 2c 1.14 (1.08–1.20) <0.001 1.07 (1.00–1.14) 0.054 1.27 (1.03–1.55) 0.024
Model 3d 1.13 (1.07–1.20) <0.001 1.08 (1.00–1.15) 0.037 1.27 (1.02–1.58) 0.037
Model 4e 1.12 (1.06–1.19) <0.001 1.08 (1.00–1.16) 0.038 1.20 (0.95–1.53) 0.132
Interaction between the number of depressive symptoms pre-MI
and increase in number of symptoms after MIf
1.00 (0.97–1.03) 0.887 1.01 (0.97–1.04) 0.692 1.14 (0.96–1.36) 0.134
Interaction between the number of depressive symptoms pre-MI
and increase in number of symptoms after MIg
1.01 (0.98–1.04) 0.719 1.01 (0.98–1.05) 0.546 1.04 (0.89–1.22) 0.613
Number of symptoms pre-MI (unadjusted) 1.00 (0.92–1.08) 0.963 0.91 (0.82–1.00) 0.049 1.12 (0.92–1.35) 0.259
Number of symptoms post-MI (unadjusted) 1.15 (1.09–1.22) <0.001 1.06 (0.97–1.17) 0.224 1.26 (1.08–1.47) 0.003
MI, Myocardial infarction ; HR, hazard ratio ; CI, conﬁdence interval ; LVEF, left ventricular ejection fraction ; PTCA, percutaneous transluminal coronary angioplasty ; CAD, coronary
artery disease.
a HRs indicate the increased risk associated with each additional symptom.
bModel 1 adjusted for age and sex.
cModel 2 adjusted for age, sex, LVEF and previous MI.
dModel 3 adjusted for age, sex, LVEF, previous MI, diabetes and smoking.
eModel 4 adjusted for age, sex, LVEF, previous MI, diabetes, smoking, anterior site MI, PTCA during hospitalization, family history of CAD and hypercholesterolaemia.
f This model included the number of depressive symptoms pre-MI, the increase in number of depressive symptoms after MI, and the interaction-term of these two.











poor prognosis : (1) in patients with depressive epi-
sodes with an onset before the MI ; and (2) when it
does not lead to a full diagnosis of depression after MI.
The association between the increase in depressive
symptoms after MI and new cardiac events suggests
that the increase in depressive symptoms as well as
the increased risk of new cardiac events have an aeti-
ology that is related to the MI, either due to the
psychological meaning or the physiological conse-
quences of the event. We found that an increase
in depressive symptoms after MI was associated
with some cardiac disease severity parameters. This
suggests that cardiac disease severity plays a role
in the increase in depressive symptoms after MI.
However, the association between the increase in de-
pressive symptoms after MI and new cardiac events
was independent of cardiac disease severity, suggest-
ing that cardiac disease severity per se does not explain
the association. Still, we would not exclude cardiac
disease severity as a potential underlying factor. Even
though an association is independent of parameters
that measure a certain underlying risk factor, the
underlying risk factor may still underlie the associ-
ation, because the parameters are inaccurately meas-
ured or there may be other inﬂuential unmeasured
parameters (Davey Smith & Phillips, 1992 ; Macleod &
Davey Smith, 2003 ; Christenfeld et al. 2004). For ex-
ample, like in most prognostic studies on depression
and cardiac disease, we measured cardiac disease se-
verity parameters only during hospitalization and
made no follow-up assessments. Therefore, we could
not evaluate whether an increase in cardiac disease
severity explained the poor prognosis in patients with
an increase in depressive symptoms after MI. In ad-
dition, unmeasured parameters, such as severity of
atherosclerosis, could explain the poor prognosis of
some patients. Another potential underlying risk fac-
tor may be inﬂammation. Higher levels of inﬂamma-
tory markers are associated with established cardiac
risk factors (such as systolic blood pressure, low-
density lipoprotein cholesterol and BMI), and an
increased risk of cardiovascular morbidity and mor-
tality (Kaptoge et al. 2010), as well as with depression
and increased depressive symptoms (Howren et al.
2009). An increase in depressive symptoms after MI
may therefore be associated with an increase in in-
ﬂammation, which in turn may explain the increased
risk of new cardiac events. Whether or not an increase
in depressive symptoms after MI is associated with
inﬂammation is yet to be investigated. Still, instead of
an underlying physiological process resulting in the
increase in depressive symptoms after MI as well as
the increased risk of new cardiac events, the increase
in depressive symptoms after MI itself may be a pre-
cursor of behavioural changes that result in an in-
creased risk of new cardiac events.
The association between an increase in depressive
symptoms after MI and new cardiac events was
weaker in depressed than in non-depressed MI
patients. A possible explanation for this diﬀerence is
that in depressed MI patients other risk factors, such
as medication non-adherence, may overrule the eﬀect
of an increase in depressive symptoms after MI.
Nevertheless, our ﬁnding shows that also in patients
who do not meet criteria for post-MI depression, those
at increased risk of new cardiac events can be ident-
iﬁed. Therefore, also in MI patients with subthreshold
levels of depression, it would be useful to assess
changes in depression after MI as a prognostic marker
for new cardiac events.
Of the patients with post-MI depression, a larger
increase in the number of depressive symptoms after
MI was associated with ﬁrst-ever depression. There
is some evidence that ﬁrst-ever depression in MI
patients is associated with poor cardiovascular out-
comes (Grace et al. 2005 ; Carney et al. 2009), but results
are inconsistent (Glassman et al. 2009 ; Zuidersma et al.
2011). In the present analysis, ﬁrst-ever depression
was not signiﬁcantly associated with an increased risk
of new cardiac events (HR for new cardiac events :
1.17, 95% CI 0.73–1.89). Although the results from the
present analysis suggest an overlap between ﬁrst-ever
depression and an increase in depressive symptoms
after MI, ﬁrst-ever depression does not seem to ex-
plain the increased risk of poor prognosis in patients
with an increase in depressive symptoms after MI.
Some considerations should be taken into account
when interpreting the ﬁndings of the present analysis.
One is the retrospective assessment of depressive
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Fig. 3.Number of new cardiac events per follow-up year with
hazard ratios (HRs) and 95% conﬁdence intervals for new
cardiac events associated with diﬀerent levels of increase in
the number of depressive symptoms just after myocardial
infarction. Values are means, with 95% conﬁdence intervals
represented by vertical bars.
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subject to recall bias. The presence of previous de-
pressive episodes in the lifetime is often under-
estimated, especially by subjects with better current
mood (Kendler et al. 2001 ; Wells & Horwood, 2004 ;
Patten, 2009). In addition, recall of depression just be-
fore MI may have been inﬂuenced by the MI itself.
Therefore, recall bias may have aﬀected the results of
the present study. However, for most participants in
the present study the recall period was no more than 4
months and Kendler et al. (2001) found recall to be
signiﬁcantly better with shorter recall periods. There-
fore, in the present analysis, underestimation of de-
pression just before MI as well as the eﬀect of current
depression severity on this underestimation may
well be less prominent. In addition, exclusion of
patients who had their depression assessed more than
3 months after the MI did not aﬀect the results, giving
a reason to believe that recall bias did not aﬀect the
results. Another consideration is that receiving psy-
chiatric treatment at the moment of the index MI was
an exclusion criterion in MIND-IT. This may have led
to the exclusion of patients who were more depressed
just before the MI, which could have inﬂuenced the
results. For DepreMI, a scheduled follow-up visit in a
non-participating hospital was an exclusion criterion,
which led to the exclusion of 44 patients. This could
have introduced some selection bias.
In summary, ﬁndings from the present study
suggest that an increase in depressive symptoms after
MI rather than prolongation of a pre-MI depressive
episode explains why post-MI depression is associated
with new cardiac events. The increased risk of new
cardiac events associated with an increase in depress-
ive symptoms after MI was higher in patients not
meeting diagnostic criteria for post-MI depression
than in those with post-MI depression. Therefore, also
in patients with subthreshold levels of depression, an
increase in depressive symptoms after MI should be
assessed as a prognostic marker. Studies should be
done to investigate whether potential mechanisms
such as cardiac disease severity and inﬂammation
underlie the association.
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